July 10th, 2009
Podcast 49: Three RASS Study researchers discuss their findings on the lack of benefit of renin-angiotensin blockade in the primary prevention of diabetic nephropathy in Type 1 diabetes.
Podcast: Play in new window | Download
Subscribe: RSS
We talk with Drs. Michael Mauer, Ronald Klein, and Bernard Zinman about their paper in the July 2 New England Journal of Medicine reporting on the RASS study (Renin-Angiotensin System Study). They found that blockade of the renin-angiotensin system was not effective in the primary prevention of diabetic nephropathy in Type 1 diabetes.
This week’s news links:
- Darvon, Darvocet to Get Stronger Warnings on Fatal Overdose Risk
- Famotidine Associated with Fewer GI Complications from Low-Dose Aspirin
- Dronedarone Approved for Maintenance Therapy in Atrial Fibrillation and Atrial Flutter
The week’s interview links:
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
